Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Neuroleptic Drugs and PACAP Differentially Affect the mRNA Expression of Genes Encoding PAC1/VPAC Type Receptors.

Jóźwiak-Bębenista M, Kowalczyk E.

Neurochem Res. 2017 Apr;42(4):943-952. doi: 10.1007/s11064-016-2127-2. Epub 2016 Nov 30.

2.

Molecular basis of major psychiatric diseases such as schizophrenia and depression.

Tohyama M, Miyata S, Hattori T, Shimizu S, Matsuzaki S.

Anat Sci Int. 2015 Jun;90(3):137-43. doi: 10.1007/s12565-014-0269-3. Epub 2015 Jan 17. Review.

PMID:
25595671
3.

The selective metabotropic glutamate 2/3 receptor agonist MGS0028 reverses psychomotor abnormalities and recognition memory deficits in mice lacking the pituitary adenylate cyclase-activating polypeptide.

Ago Y, Hiramatsu N, Ishihama T, Hazama K, Hayata-Takano A, Shibasaki Y, Shintani N, Hashimoto H, Kawasaki T, Onoe H, Chaki S, Nakazato A, Baba A, Takuma K, Matsuda T.

Behav Pharmacol. 2013 Feb;24(1):74-7. doi: 10.1097/FBP.0b013e32835cf3e5.

PMID:
23268987
4.
5.

Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction.

Ayalew M, Le-Niculescu H, Levey DF, Jain N, Changala B, Patel SD, Winiger E, Breier A, Shekhar A, Amdur R, Koller D, Nurnberger JI, Corvin A, Geyer M, Tsuang MT, Salomon D, Schork NJ, Fanous AH, O'Donovan MC, Niculescu AB.

Mol Psychiatry. 2012 Sep;17(9):887-905. doi: 10.1038/mp.2012.37. Epub 2012 May 15.

6.

Replication study of association between ADCYAP1 gene polymorphisms and schizophrenia.

Koga M, Ishiguro H, Horiuchi Y, Inada T, Ujike H, Itokawa M, Otowa T, Watanabe Y, Someya T, Arinami T.

Psychiatr Genet. 2010 Jun;20(3):123-5. doi: 10.1097/YPG.0b013e32833a1f52.

PMID:
20414143
7.

Role of the PACAP-PAC1-DISC1 and PACAP-PAC1-stathmin1 systems in schizophrenia and bipolar disorder: novel treatment mechanisms?

Katayama T, Hattori T, Yamada K, Matsuzaki S, Tohyama M.

Pharmacogenomics. 2009 Dec;10(12):1967-78. doi: 10.2217/pgs.09.147. Review.

PMID:
19958095
8.

Possible association between the pituitary adenylate cyclase-activating polypeptide (PACAP) gene and major depressive disorder.

Hashimoto R, Hashimoto H, Shintani N, Ohi K, Hori H, Saitoh O, Kosuga A, Tatsumi M, Iwata N, Ozaki N, Kamijima K, Baba A, Takeda M, Kunugi H.

Neurosci Lett. 2010 Jan 14;468(3):300-2. doi: 10.1016/j.neulet.2009.11.019. Epub 2009 Nov 13.

PMID:
19914336
9.

Regulation of pituitary adenylyl cyclase-activating polypeptide (PACAP, ADCYAP1: adenylyl cyclase-activating polypeptide 1) in the treatment of schizophrenia.

Matsuzaki S, Tohyama M.

Expert Opin Ther Targets. 2008 Sep;12(9):1097-108. doi: 10.1517/14728222.12.9.1097 . Review.

PMID:
18694377
10.

Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia.

Hashimoto R, Hashimoto H, Shintani N, Chiba S, Hattori S, Okada T, Nakajima M, Tanaka K, Kawagishi N, Nemoto K, Mori T, Ohnishi T, Noguchi H, Hori H, Suzuki T, Iwata N, Ozaki N, Nakabayashi T, Saitoh O, Kosuga A, Tatsumi M, Kamijima K, Weinberger DR, Kunugi H, Baba A.

Mol Psychiatry. 2007 Nov;12(11):1026-32. Epub 2007 Mar 27.

PMID:
17387318
11.

Association analysis of the pituitary adenyl cyclase activating peptide gene (PACAP) on chromosome 18p11 with schizophrenia and bipolar disorders.

Ishiguro H, Ohtsuki T, Okubo Y, Kurumaji A, Arinami T.

J Neural Transm (Vienna). 2001;108(7):849-54.

PMID:
11515750

Supplemental Content

Loading ...
Support Center